Bausch Health
BHC
#4091
Rank
โ‚น289.11 B
Marketcap
โ‚น772.48
Share price
-2.08%
Change (1 day)
36.14%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Operating Margin for Bausch Health (BHC)

Operating Margin as of November 2026 (TTM): 3.57%

According to Bausch Health 's latest financial reports and stock price the company's current Operating Margin is 3.57%. At the end of 2022 the company had an Operating Margin of -1.59%.

Operating Margin history for Bausch Health from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-1.59%-86.92%
2021-12.14%4.35%
2020-11.64%-45.52%
2019-21.36%-56.91%
2018-49.57%148.39%
2017-19.96%-20.72%
2016-25.17%1962.92%
2015-1.22%-109.23%
201413.22%-158.04%
2013-22.78%104.96%
2012-11.12%1421.26%
2011-0.73%-96.35%
2010-20.00%-193.79%
200921.32%27.24%
200816.76%-32.33%
200724.77%19.27%
200620.77%59.04%
200513.06%87.62%
20046.96%-283.35%
2003-3.80%-127.37%
200213.87%-21.26%
200117.61%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-13.57%-480.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-8,391.15%-235,146.22%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.